PGT-A

Our unique AI innovation improves the odds of pregnancy and IVF success

The only test using artificial intelligence (AI) based on clinical outcome data, eliminating subjectivity, and improving accuracy. Our PGT-A provides greater confidence in robust and accurate results with two independent analyses (CNV and SNP) to check for abnormalities³

Parental QC*

Patients are seeking reassurance of the parentage of their embryos.

Today’s IVF patient is more educated, motivated, and involved in their treatment than ever before. Patient concerns about ensuring the parentage of their embryos have been raised due to highly-publicized reports of IVF mix-ups.

The new Parental QC assessment included in the PGT-Complete analysis confirms a match** between the embryo biopsy sample and the provided parental samples. This reduces the anxiety of potential mix-ups for you and your patients.

* Parental QC is not reported in countries (e.g. UK) where it is not permitted by regulatory bodies.
**A match is defined as a genetic analysis that is consistent with a shared inheritance and familial relationship between the parental samples and the embryo biopsy sample

Genetic PN check

Empowering additional embryo transfers

We understand that visual inspection of correct embryo fertilization is challenging, as

• PN may appear at slightly different times
• PN may be faint or have already faded
• A micro PN may be apparent
• PN may be vertically stacked making identification difficult Our PGT-Complete test not only confirms correct embryo fertilization, it also enables testing of morphologically identified 0, 1 and 3PN embryos. This empowers your embryology team by allowing more embryos to be tested and therefore considered for transfer.

Let us provide your team with genetic information of correct embryo fertilization.

Arming your teams with the ability to identify and rescue true 2PN embryos, thus enabling additional embryo transfers.²

Origin of aneuploidy

Empowering your patients

The origin of aneuploidy feature included in our PGT-Complete analysis provides a direct assessment of gametic contribution to embryo aneuploidy, helping your patient make informed donor gamete decisions.

For patients considering donor gametes it is important to understand that not all aneuploidy is maternally derived, as often paternal contribution to aneuploidy can be overlooked.